Yaniv is a versatile business lawyer. He has expertise in domestic and cross-border transactions, including mergers and acquisitions, joint ventures, carveouts, reorganizations and other strategic transactions. His expertise also includes “add on” and “roll up” acquisition strategies, including in highly regulated industries such as the veterinary sector.
His clients include private and public companies, entrepreneurs, family offices, private equity and venture capital funds and pension funds.
Yaniv’s private equity and venture capital practice includes fund formation. He also advises institutional investors, such as pension funds, in connection with investments in private funds.
He regularly assists foreign clients interested in expanding into Canada, which includes setting up new Canadian subsidiaries or investing in or acquiring existing Canadian businesses.
Experience
- Advised Trive Capital in connection with its investment in Crunch Canada.
- Advised the management and employee shareholders of Englobe Corp. in connection with the acquisition of Englobe by Colliers.
- Advised Artelia in connection with its acquisition of FNX-Innov.
- Advised Alcumus Group Limited in connection with its acquisition of Cognibox.
- Advised Ingersoll Rand in connection with its acquisition of Maximus.
- Advised VetStrategy and Groupe Vétérinaire Daubigny in connection with Berkshire Partners’ acquisition of a majority stake in VetStrategy from Imperial Capital.
- Advised Covea Group, a shareholder of La Capitale, in the context of La Capitale’s merger transaction with SSQ.
- Advised Groupe Vétérinaire Daubigny in multiple add-on acquisitions of veterinary clinics and hospitals in the Province of Quebec.
- Advised Panache Ventures in their first fund formation.
- Advised CiToxLAB Group Inc. in connection with its acquisition of AccelLAB Inc.
- Advised O'Leary Funds Management LP in connection with the sale of its mutual fund business to Canoe Financial LP.
- Advised Doris Inc. and its shareholders in connection with the sale of Doris' Canadian, U.S. and Hong Kong business to Gildan Activewear Inc.
- BDC Venture Capital and Investissement Québec in the context of their investment in White Star Capital.
- Strides Arcolab Limited in the context of the sale of its Agila Specialties Pharma Corporation business to Mylan Inc.
- Advised Institutional investors in respect of their investment in iNovia Fund III.
- Advised Trive Capital in connection with its investment in Crunch Canada.
- Advised the management and employee shareholders of Englobe Corp. in connection with the acquisition of Englobe by Colliers.
- Advised Artelia in connection with its acquisition of FNX-Innov.
- Advised Alcumus Group Limited in connection with its acquisition of Cognibox.
- Advised Ingersoll Rand in connection with its acquisition of Maximus.
- Advised VetStrategy and Groupe Vétérinaire Daubigny in connection with Berkshire Partners’ acquisition of a majority stake in VetStrategy from Imperial Capital.
- Advised Covea Group, a shareholder of La Capitale, in the context of La Capitale’s merger transaction with SSQ.
- Advised Groupe Vétérinaire Daubigny in multiple add-on acquisitions of veterinary clinics and hospitals in the Province of Quebec.
- Advised Panache Ventures in their first fund formation.
- Advised CiToxLAB Group Inc. in connection with its acquisition of AccelLAB Inc.
- Advised O'Leary Funds Management LP in connection with the sale of its mutual fund business to Canoe Financial LP.
- Advised Doris Inc. and its shareholders in connection with the sale of Doris' Canadian, U.S. and Hong Kong business to Gildan Activewear Inc.
- BDC Venture Capital and Investissement Québec in the context of their investment in White Star Capital.
- Strides Arcolab Limited in the context of the sale of its Agila Specialties Pharma Corporation business to Mylan Inc.
- Advised Institutional investors in respect of their investment in iNovia Fund III.
